GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » 3-Year Revenue Growth Rate

Instituto Rosenbusch (BUE:ROSE) 3-Year Revenue Growth Rate : 75.10% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch 3-Year Revenue Growth Rate?

Instituto Rosenbusch's Revenue per Share for the three months ended in Mar. 2024 was ARS46.01.

During the past 12 months, Instituto Rosenbusch's average Revenue per Share Growth Rate was 28.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 75.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 67.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 51.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Instituto Rosenbusch was 96.80% per year. The lowest was -80.70% per year. And the median was 15.90% per year.

Competitive Comparison of Instituto Rosenbusch's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instituto Rosenbusch's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's 3-Year Revenue Growth Rate falls into.


Instituto Rosenbusch 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Instituto Rosenbusch  (BUE:ROSE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Instituto Rosenbusch 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Instituto Rosenbusch (BUE:ROSE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » 3-Year Revenue Growth Rate
Comparable Companies
BSP:ARXD11 BSP:DMVF3 BSP:SNCI11 BSP:NUTR3 BSP:JOPA3 BSP:HUCG11 BSP:DTCY3 BSP:FATN11 BSP:DVFF11 BSP:BMIN3 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Website
https://www.rosenbusch.com
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.